CervoMed Inc. Common Stock (CRVO)
CervoMed Inc. (CRVO) is a biotechnology company focused on developing innovative therapeutics for neurodegenerative and inflammatory diseases. The company leverages advanced scientific research to create novel treatment options aimed at improving patient outcomes in areas with significant unmet medical needs.
Company News
CervoMed, a clinical-stage company developing treatments for neurologic disorders, will participate in the 4th Annual ROTH Healthcare Opportunities Conference in New York on October 9, 2025, presenting on small firms addressing major medical indications.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Canaccord Genuity boosted the price target for CervoMed Inc. (NASDAQ: CRVO) from $50 to $65. Canaccord Genuity analyst Sumant Kulkarni maintained a Buy rati...